Paradoxical elevation of serum TRACP5b levels despite increase in lumbar spine bone mineral density during anti-TNFα therapy in patients with inflammatory rheumatic disease: a 2-year prospective assessment of bone mass, bone metabolism, and the trabecular
Fiche publication
Date publication
septembre 2017
Journal
European journal of rheumatology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr TOUSSIROT Eric
Tous les auteurs :
Toussirot É, Mourot L, Dehecq B, Michel F, Wendling D, Grandclément É, Dumoulin G
Lien Pubmed
Résumé
To examine the impact of long-term anti-TNFα therapy on bone mass, bone metabolism, and the trabecular bone score (TBS) in patients with rheumatoid arthritis (RA) or ankylosing spondylitis (AS).
Mots clés
TNFα inhibitors, TRACP5b, bone markers, bone mineral density, trabecular bone score
Référence
Eur J Rheumatol. 2017 Sep;4(3):189-193